Deltagen Inc.
DGEN - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.86K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3,859.00 |
|---|---|
| Enterprise Value | $-2,670,141.00 |
| Earnings per Share | $0 |
| Beta | 2.49 |
| Outstanding Shares | 0 |
Return
| Return on Equity | 31.60% |
|---|---|
| Return on Assets | 29.27% |
| Return on Invested Capital | 9.28% |
Valuation & Multiples
| P/E Ratio | 0.04 |
|---|---|
| PEG | -0.04 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -0.52 |
| Enterprise Value to EBIT | -4.66 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Deltagen Inc.
0CEO: Robert J. Driscoll
Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as sm...